ZIVO Bioscience to Present at the Q3 Virtual Investor Summit

Keego Harbor, Michigan--(Newsfile Corp. - August 11, 2021) - ZIVO Bioscience (NASDAQ: ZIVO) today announced that Andrew Dahl will be attending the Q3 Virtual Investor Summit.

About ZIVO Bioscience

ZIVO Bioscience, Inc. (NASDAQ: ZIVO), is a biotech/agtech R&D company engaged in the development and commercialization of therapeutic, medicinal and nutritional bioproduct candidates originally derived from proprietary algal cultures.

For further information:

ZIVO Bioscience
Christine Rich
248-452-9866
[email protected]

About the Investor Summit

The Investor Summit is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors. The Q3 Investor Summit will take place virtually, featuring 80+ companies and over 800 investors, consisting of institutional investors, family offices, and private wealth.

To request complimentary investor registration: please click here: Complimentary Investor Registration

Contact:

Sasha Murray at [email protected]

You May Also Be Interested In

• Clean Air Metals and Fiore-Backed Springbok Ventures Announce Strategic Business Combination
• American Freight Helps Families and College Students Stretch Their Budget This Back-to-School Season
• GolfStatus and Dormie Network Open Nominations for the Sixth Annual Play It Forward Campaign